home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

39.22 +0.62 (+1.59%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying ↗

April 22, 2024

Via Benzinga

Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing

April 02, 2024

From Melt Pharmaceuticals, Inc.

Via Business Wire

Insiders Buying Greenwich LifeSciences And 2 Other Stocks ↗

March 25, 2024

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

Via Benzinga

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 20, 2024

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...

Via Benzinga

Harrow: Q4 Earnings Insights ↗

March 19, 2024

Via Benzinga

INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost ↗

March 20, 2024

Intel stock is rising on Wednesday as investors in INTC shares react to the semiconductor company securing $8.5 billion in funding.

Via InvestorPlace

Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today? ↗

March 20, 2024

Aquestive Therapeutics stock is falling on Wednesday after the company price a public offering for AQST shares this morning.

Via InvestorPlace

Why Is Harrow (HROW) Stock Up 5% Today? ↗

March 20, 2024

Harrow stock is up on Wednesday as investors in HROW shares react to the company's earnings report for the fourth quarter of 2023!

Via InvestorPlace

Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket ↗

March 20, 2024

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 20, 2024

Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning!

Via InvestorPlace

Earnings Preview: Harrow Health ↗

March 18, 2024

Via Benzinga

Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 20, 2024

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

Via Benzinga

Topics Stocks

HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023 ↗

March 19, 2024

HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Harrow Announces Fourth Quarter and Year-End 2023 Financial Results

March 19, 2024

From Harrow, Inc.

Via Business Wire

Earnings Scheduled For March 19, 2024 ↗

March 19, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024

March 05, 2024

From Harrow, Inc.

Via Business Wire

Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products

February 15, 2024

From Harrow, Inc.

Via Business Wire

Harrow Announces New Appointments to its Board of Directors

January 29, 2024

From Harrow, Inc.

Via Business Wire

Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease

January 11, 2024

From Harrow, Inc.

Via Business Wire

Melt Pharmaceuticals Provides Corporate Update

January 03, 2024

From Melt Pharmaceuticals, Inc.

Via Business Wire

Harrow Partners with Leading Healthcare Market Access Technology Platforms

January 03, 2024

From Harrow, Inc.

Via Business Wire

7 Short-Squeeze Stocks That Are Screaming for Speculation ↗

December 24, 2023

If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you.

Via InvestorPlace

Harrow Completes Transfer of the TRIESENCE® New Drug Application

November 29, 2023

From Harrow, Inc.

Via Business Wire

Harrow to Present at Two Investor Conferences in November

November 20, 2023

From Harrow, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 14, 2023

Via Benzinga

Why Is Eyecare-Focused Harrow Health Stock Trading Lower Today? ↗

November 14, 2023

Harrow Health Inc (NASDAQ: HROW) reported Q3 revenues of $34.3 million, an increase of 50% Y/Y, missing the consensus of $37

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 14, 2023

Via Benzinga

Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket ↗

November 14, 2023

INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter.

Via Benzinga

Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 14, 2023

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com